| Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats N Lomeli, K Di, J Czerniawski, JF Guzowski, DA Bota Free Radical Biology and Medicine 102, 274-286, 2017 | 143 | 2017 |
| Diminished stress resistance and defective adaptive homeostasis in age-related diseases N Lomeli, DA Bota, KJA Davies Clinical Science 131 (21), 2573-2599, 2017 | 38 | 2017 |
| Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood T John, N Lomeli, DA Bota Behavioural brain research 319, 200-206, 2017 | 37 | 2017 |
| Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma K Di, N Lomeli, SD Wood, CD Vanderwal, DA Bota Oncotarget 7 (47), 77457, 2016 | 32 | 2016 |
| Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons N Lomeli, K Di, DC Pearre, TF Chung, DA Bota Mitochondrion 52, 56-66, 2020 | 18 | 2020 |
| Magmas inhibition as a potential treatment strategy in malignant glioma K Di, N Lomeli, DA Bota, BC Das Journal of neuro-oncology 141, 267-276, 2019 | 12 | 2019 |
| Cognitive complications of cancer and cancer-related treatments–Novel paradigms N Lomeli, J Lepe, K Gupta, DA Bota Neuroscience letters 749, 135720, 2021 | 11 | 2021 |
| Feasibility of cognitive training to promote recovery in cancer-related cognitive impairment in adolescent and young adult patients M Gooch, A Mehta, T John, N Lomeli, E Naeem, G Mucci, YL Toh, A Chan, ... Journal of adolescent and young adult oncology 11 (3), 290-296, 2022 | 8 | 2022 |
| A prospective, cohort study of SITOIGANAP to treat glioblastoma when given in combination with granulocyte-macrophage colony-stimulating factor/cyclophosphamide/bevacizumab … DA Bota, TH Taylor, N Lomeli, XT Kong, BD Fu, AH Schönthal, S Singer, ... Frontiers in Oncology 12, 934638, 2022 | 4 | 2022 |
| Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic N Lomeli, DA Bota Translational cancer research 7 (4), 6215, 2018 | 4 | 2018 |
| A novel rat ovarian cancer model developed to examine chemotherapy-related cognitive impairments D Pearre, N Lomeli, D Bota Gynecologic Oncology 156 (3), e4, 2020 | 3 | 2020 |
| Cisplatin induces mitochondrial damage and hippocampal neurotoxicity: a potential mechanism for chemotherapy-related cognitive impairment N Lomeli, J Czerniawski, K Di, J Guzowski, D Bota Cancer Research 76 (14_Supplement), 4782-4782, 2016 | 2 | 2016 |
| LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma C Douglas, N Lomeli, T Vu, J Pham, DA Bota bioRxiv, 2023 | 1 | 2023 |
| NCMP-13. BDNF enhancement via ampakines as a potential treatment for chemotherapy-related cognitive impairment N Lomeli, D Pearre, K Di, D A Bota Neuro-oncology 20 (Suppl 6), vi196-vi196, 2018 | 1 | 2018 |
| Marizomib activity as a single agent in malignant gliomas: Ability to cross the blood brain barrier. DA Bota, FPK Hsu, K Di, V Abraham, N Lomeli, GK Lloyd, F Burrows, ... Journal of Clinical Oncology 33 (15_suppl), e12644-e12644, 2015 | 1 | 2015 |
| Translational models of ovarian cancer-associated cognitive impairment and chemotherapy-induced peripheral neuropathy N Lomeli, D Argueta, DC Pearre, J Lepe, K Gupta, DA Bota Cancer Research 84 (6_Supplement), 7451-7451, 2024 | | 2024 |
| Targeting Lon protease as novel strategy to treat aggressive IDH mutant diffuse malignant astrocytoma C Douglas, S Jain, N Lomeli, T Vu, J Pham, DA Bota Cancer Research 84 (6_Supplement), 4731-4731, 2024 | | 2024 |
| Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity N Lomeli, DC Pearre, M Cruz, K Di, JL Ricks-Oddie, DA Bota Experimental Neurology, 114717, 2024 | | 2024 |
| Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma BC Das, JJ Lepe, MA Shareef, N Lomeli, S Das, DA Bota Bioorganic & medicinal chemistry letters 91, 129330, 2023 | | 2023 |
| Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models C Douglas, N Lomeli, J Lepe, K Di, NK Nandwana, T Vu, J Pham, ... bioRxiv, 2023 | | 2023 |
